Alkosign Limited (BOM:543453)
India · Delayed Price · Currency is INR 60.41
0.00 (0.00%)
At close: Aug 18, 2026
Alkosign Revenue
In the fiscal year ending March 31, 2026, Alkosign had annual revenue of 266.98M INR, down -48.19%.
Revenue
266.98M
Revenue Growth
-42.34%
P/S Ratio
3.66
Revenue / Employee
n/a
Employees
82
Market Cap
977.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 266.98M | -248.32M | -48.19% |
| Mar 31, 2025 | 515.31M | 158.44M | 44.40% |
| Mar 31, 2024 | 356.87M | 143.09M | 66.94% |
| Mar 31, 2023 | 213.78M | 112.17M | 110.40% |
| Mar 31, 2022 | 101.61M | -30.91M | -23.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NIS Management | 4.49B |
| Aban Offshore | 4.33B |
| M P K Steels (I) | 2.59B |
| Calcom Vision | 2.36B |
| Gabion Technologies India | 1.15B |
| Raaj Medisafe India | 936.47M |
| Veerhealth Care | 532.37M |
| Milgrey Finance and Investments | 217.93M |